| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,148 |
27,731 |
$1.68M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,902 |
7,549 |
$587K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,022 |
4,987 |
$346K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,271 |
1,268 |
$117K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,801 |
2,540 |
$90K |
| 99058 |
|
1,371 |
1,218 |
$87K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,730 |
5,544 |
$53K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,081 |
3,550 |
$33K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
352 |
349 |
$29K |
| 99000 |
|
6,786 |
6,349 |
$26K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
883 |
859 |
$21K |
| 99051 |
|
13,352 |
12,538 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
6,168 |
5,968 |
$19K |
| 93000 |
|
1,056 |
1,035 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
568 |
439 |
$7K |
| 81002 |
|
2,332 |
2,256 |
$5K |
| 90756 |
|
179 |
175 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
256 |
248 |
$4K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
626 |
601 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,654 |
1,505 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
302 |
296 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
49 |
49 |
$2K |
| 90686 |
|
71 |
71 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$1K |
| 90688 |
|
55 |
55 |
$942.21 |
| 84703 |
|
101 |
98 |
$449.38 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
529 |
507 |
$404.67 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
170 |
169 |
$171.30 |
| 94760 |
|
216 |
208 |
$2.70 |
| 3074F |
|
1,570 |
1,545 |
$0.09 |
| 3079F |
|
183 |
182 |
$0.05 |
| 3078F |
|
1,174 |
1,157 |
$0.04 |
| 3008F |
|
1,050 |
1,044 |
$0.01 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
107 |
104 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
926 |
912 |
$0.00 |
| 3044F |
|
288 |
283 |
$0.00 |
| 3048F |
|
103 |
101 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
33 |
33 |
$0.00 |